The Company of Biologists renews Read & Publish agreement with EIFL to expand Open Access publishing opportunities
15 September 2023
The Company of Biologists is delighted to announce the renewal and expansion of our Read & Publish Open Access agreement with Electronic Information for Libraries (EIFL) from 2024-2026.
From 2024, corresponding authors in 30 developing and transition economy countries can now benefit from publishing an uncapped number of Open Access research articles in our two fully Open Access journals – Disease Models & Mechanisms and Biology Open in addition to our hybrid journals, Development, Journal of Cell Science and Journal of Experimental Biology without paying an article processing charge (APC). Researchers at participating institutions also benefit from unlimited access to the journals and their archives dating back to 1853.
Albania, Armenia, Azerbaijan, Congo, Côte d’Ivoire, Ethiopia, Fiji, Georgia, Ghana, Kenya, Kosovo, Kyrgyzstan, Laos, Lesotho, Malawi, Maldives, Moldova, Myanmar, Namibia, Nepal, North Macedonia, Palestine, Senegal, Sudan, Tanzania, Uganda, Ukraine, Uzbekistan, Zambia, Zimbabwe.
Lorraine Estelle, Licensing Programme Manager, EIFL, says:
“We are glad that corresponding authors from EIFL partner countries will be able to publish Open Access in all The Company of Biologists’ journals. We value the partnership with the Company and welcome the extension of the agreement for three more years for free access and publishing for 30 EIFL partner countries.”
Shelly Turner, Head of Sales and Business Development at The Company of Biologists, says:
“We are delighted that our continuing partnership with EIFL has enabled us to expand the number of journals from three to five from 2024 which will in turn offer more opportunities for authors in 30 developing and transition economy countries to submit fee-free Open Access articles.”
EIFL (Electronic Information for Libraries) is a not-for-profit organisation that works with libraries to enable access to knowledge in developing and transition economy countries in Africa, Asia Pacific, Europe and Latin America.
EIFL runs a number of programmes to enable access to knowledge for education, learning, research and sustainable community development. This includes negotiating agreements with publishers to secure affordable access to e-resources as well as Open Access publishing terms on behalf of libraries and authors in EIFL partner countries.
Further information about fee-free Open Access publishing can be found on the EIFL website.
About The Company of Biologists
The Company of Biologists is a not-for-profit publishing organisation dedicated to supporting and inspiring the biological community. We partner with libraries and library consortia to enable biologists worldwide to access our leading peer-reviewed hybrid journals – Development, Journal of Cell Science and Journal of Experimental Biology.
We have a long-standing and ongoing commitment to Open Access. Our cost-neutral Read & Publish initiative enables corresponding authors at participating institutions to publish an uncapped number of OA research articles in our hybrid journals and our two fully OA journals – Disease Models & Mechanisms and Biology Open without paying an Article Processing Charge (APC). We were the first not-for-profit publisher to commit to the Transformative Journal approach and our journals were the first to be awarded Transformative Journal status by Plan S. Over 650 institutions in 41 countries are now participating in our cost-neutral Read & Publish OA initiative. We also have Read & Publish agreements with many library consortia.